Dr. Haifaa Abdulhaq, MD
Claim this profileCommunity Cancer Institute
Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
9 reported clinical trials
30 drugs studied
Area of expertise
1Acute Myelogenous Leukemia
t(8;21) negative
inv(16) negative
t(16;16) negative
2Acute Myeloid Leukemia
t(8;21) negative
inv(16) negative
t(16;16) negative
Affiliated Hospitals
Clinical Trials Haifaa Abdulhaq, MD is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
Triple Drug Therapy
for Follicular Lymphoma
This phase II trial studies how well obinutuzumab, ibrutinib, and venetoclax work in treating patients with previously untreated stage II-IV follicular lymphoma. Immunotherapy with obinutuzumab may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Ibrutinib and venetoclax may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving obinutuzumab, ibrutinib, and venetoclax together may work better in treating follicular lymphoma compared to each drug alone.
Recruiting1 award Phase 210 criteria
More about Haifaa Abdulhaq, MD
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Haifaa Abdulhaq, MD has experience with
- Cytarabine
- Daunorubicin
- Venetoclax
- Obinutuzumab
- Ibrutinib
- Geriatric Assessment
Breakdown of trials Haifaa Abdulhaq, MD has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Follicular Lymphoma
Lymphoma
Survivorship
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Haifaa Abdulhaq, MD specialize in?
Haifaa Abdulhaq, MD focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved t(8;21) negative patients, or patients who are inv(16) negative.
Is Haifaa Abdulhaq, MD currently recruiting for clinical trials?
Yes, Haifaa Abdulhaq, MD is currently recruiting for 5 clinical trials in Clovis California. If you're interested in participating, you should apply.
Are there any treatments that Haifaa Abdulhaq, MD has studied deeply?
Yes, Haifaa Abdulhaq, MD has studied treatments such as Cytarabine, Daunorubicin, Venetoclax.
What is the best way to schedule an appointment with Haifaa Abdulhaq, MD?
Apply for one of the trials that Haifaa Abdulhaq, MD is conducting.
What is the office address of Haifaa Abdulhaq, MD?
The office of Haifaa Abdulhaq, MD is located at: Community Cancer Institute, Clovis, California 93611 United States. This is the address for their practice at the Community Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.